Clinical Trial Update: Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset Seizures

View source ↗

Summary

Clinical trial assessing Briviact as add-on therapy for epilepsy with partial-onset seizures has completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy with Partial Onset Seizures

Drugs mentioned

• Briviact (brivaracetam)

Snippet

Sponsor: UCB Biopharma S.P.R.L. | Conditions: Epilepsy With POS With or Without Secondary Generalization | Status: COMPLETED | Results posted: 2021-08-04